ARCHIVES

CTEP Drafts FDA Approval Guidelines

This article is from The Cancer Letter archive.

Vol. 14 No. 10 | March 4, 1988

Download PDF Visit The Full Archive

Related Articles

FDA Approves Xeloda For Colon Cancer; Phase III Data Not Reviewed By ODAC.

May 4, 2001

Healy Comes To Defense Of NCI’s Robert Wittes; Official Has Been Target Of Innuendo Over Taxo

September 11, 1992

Also Von Eschenbach role in industry program raises new concerns of conflict of interest.

November 23, 2005

AACR Elion Award Deadline Is Jan. 10

September 16, 1994

NCI FY 1991 Operating Budget Outlined In Chart

December 7, 1990

Once again, Broder Asked What Would He Recommend To Women Aged 40-49

March 18, 1994